The first software as medical device of evidence-based hypertension digital therapeutics for clinical practice

In 2021, the open-label randomized HERB-Digital Hypertension 1 (HERB-DH1) trial showed for the first time that hypertension digital therapeutics (a hypertension treatment app) successfully reduced blood pressure (BP) in patients with hypertension. Patients in the digital therapeutics group who used...

Descripción completa

Detalles Bibliográficos
Autores principales: Kario, Kazuomi, Harada, Noriko, Okura, Ayako
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540047/
https://www.ncbi.nlm.nih.gov/pubmed/36207530
http://dx.doi.org/10.1038/s41440-022-01016-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540047/
https://www.ncbi.nlm.nih.gov/pubmed/36207530
http://dx.doi.org/10.1038/s41440-022-01016-w

Ejemplares similares